These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39312984)
1. Controlled release of doxorubicin from Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by coaxial electrospraying. Liu Y; Craig DQM; Parhizkar M Int J Pharm; 2024 Dec; 666():124724. PubMed ID: 39312984 [TBL] [Abstract][Full Text] [Related]
2. Electrohydrodynamic fabrication of core-shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment. Reardon PJ; Parhizkar M; Harker AH; Browning RJ; Vassileva V; Stride E; Pedley RB; Edirisinghe M; Knowles JC Int J Nanomedicine; 2017; 12():3913-3926. PubMed ID: 28579777 [TBL] [Abstract][Full Text] [Related]
3. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading. Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459 [TBL] [Abstract][Full Text] [Related]
6. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Amjadi I; Rabiee M; Hosseini MS; Mozafari M Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852 [TBL] [Abstract][Full Text] [Related]
8. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related]
9. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications. Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug. Boddu SH; Jwala J; Chowdhury MR; Mitra AK J Ocul Pharmacol Ther; 2010 Oct; 26(5):459-68. PubMed ID: 20874666 [TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Misra R; Sahoo SK Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929 [TBL] [Abstract][Full Text] [Related]
13. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation. Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676 [TBL] [Abstract][Full Text] [Related]
14. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin. Li F; Sun J; Zhu H; Wen X; Lin C; Shi D Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Wang S; Zhang J; Wang Y; Chen M Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968 [TBL] [Abstract][Full Text] [Related]
17. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL; Zheng CL; Liu JP; Zhu JB Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer. Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH Int J Nanomedicine; 2011; 6():1415-27. PubMed ID: 21796244 [TBL] [Abstract][Full Text] [Related]
19. Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor. Xu J; Zhang S; Machado A; Lecommandoux S; Sandre O; Gu F; Colin A Sci Rep; 2017 Jul; 7(1):4794. PubMed ID: 28684775 [TBL] [Abstract][Full Text] [Related]
20. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]